Table 1.
Amount of source ingredients used to synthesize the formulations.
| Lecithin | Cholesterol | DSPE-PEG2000 | CB | DOX | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| mg | mM | mg | mM | mg | mM | mg | mM | mg | mM | |
| Lip | 21.6 | 4.0 | 8 | 2.9 | N/A | N/A | N/A | N/A | N/A | N/A |
| PEG-Lip | 21.6 | 4.0 | 8 | 2.9 | 7.3 | 361.4 | N/A | N/A | N/A | N/A |
| Lip-CB | 21.6 | 4.0 | 8 | 2.9 | N/A | N/A | 12 | 4.5 | N/A | N/A |
| PEG-Lip-CB | 21.6 | 4.0 | 8 | 2.9 | 7.3 | 361.4 | 12 | 4.5 | N/A | N/A |
| Lip-DOX | 21.6 | 4.0 | 8 | 2.9 | N/A | N/A | N/A | N/A | 12 | 2.9 |
| PEG-Lip-DOX | 21.6 | 4.0 | 8 | 2.9 | 7.3 | 361.4 | N/A | N/A | 12 | 2.9 |
| Lip-DOX/CB | 21.6 | 4.0 | 8 | 2.9 | N/A | N/A | 6.0 | 2.2 | 6 | 1.4 |
| PEG-Lip-DOX/CB | 21.6 | 4.0 | 8 | 2.9 | 7.3 | 361.4 | 6.0 | 2.2 | 6 | 1.4 |
N/A: Not applicable.